HEALTH/SICKLE CELL ANEM: Recognizes gene editing as a significant advancement in the treatment of sickle cell disease

This legislative resolution formally recognizes gene editing as a major advancement in treating sickle cell disease. It does not create new laws, fund programs, or change existing regulations, but rather serves as a symbolic statement of appreciation for scientific progress in this medical field. The text was amended to correct a minor typo and to specify the title of the Sickle Cell Disease Association of America, Inc., Northwest Louisiana Chapter. Ultimately, the bill functions as a commemorative measure that acknowledges the importance of gene editing technology for patients with sickle cell disease.